Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDFT1 | P37268 | 14/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8947220 | 0.91 | FDFT1 (0.44) | FDFT1 | |
| SCHEMBL9162239 | 0.90 | FDFT1 (0.45) | FDFT1 | |
| SCHEMBL9162413 | 0.89 | FDFT1 (0.44) | FDFT1 | |
| SCHEMBL8947185 | 0.84 | FDFT1 (0.53) | FDFT1 | |
| SCHEMBL8947024 | 0.83 | FDFT1 (0.43) | FDFT1 | |
| SCHEMBL8947012 | 0.81 | FDFT1 (0.44) | FDFT1 | |
| SCHEMBL8824814 | 0.79 | FDFT1 (0.45) | FDFT1 | |
| SCHEMBL8824799 | 0.79 | FDFT1 (0.45) | FDFT1 | |
| SCHEMBL8898240 | 0.77 | FDFT1 (0.45) | FDFT1 | |
| SCHEMBL8898008 | 0.76 | FDFT1 (0.43) | FDFT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5470845-A | Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-11-28 | — | — | US | claimed |
| EP-0595635-A1 | Alpha-phosphorous substituted sulfonate derivatives as squalene synthetase inhibitors | E.R. Squibb & Sons, Inc. (US) | 1994-05-04 | — | — | EP | claimed |
| US-5567841-A | ANTICHOLESTEROL AGENT | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-10-22 | — | — | US | disclosed |
| US-5470845-A | Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-11-28 | — | — | US | disclosed |
| EP-0595635-A1 | Alpha-phosphorous substituted sulfonate derivatives as squalene synthetase inhibitors | E.R. Squibb & Sons, Inc. (US) | 1994-05-04 | — | — | EP | disclosed |